Observation on IPO of US stocks
Listing of new shares:
- Arcellx (ACLX), a cancer immunotherapy biomedical company, rose 12% on the first day;
The rest were delayed from listing
IPO this week:
February 7th:
- Diversified investment company Marygold Companies (The Marygold Companies, Inc. (aka Concierge Technologies, Inc.)$(MGLD)$)
- Advertising technology platform Direct Digital (Direct Digital Holdings, Inc.$(DRCT)$)
- Indoor shrimp company tru Shrimp (tru Shrimp Companies, Inc.$(BTRU)$)
- Clean energy technology solutions company Vivakor (< a href= "https://laohu8.com/S/Vivk "> $(Vivk) $)
Feb. 9: Digital media company The Arena Group (The Arena Group (aka theMaven, Inc.)$(AREN)$)
February 10:
- Meihua International, a disposable medical device supplier (Meihua International Medical Technologies$(MHUA)$)
- Short rent apartment operator CorpHousing Group (CorpHousing Group$(CHG)$)
- Japanese software development company HEARTCORE (HeartCore Enterprises$(HTCR)$)
February 11th:
- Sky Technologies, an electrical technology company (Sky Technologies$(SKYX)$)
- Sustainable bedding company Cariloha, Inc. (Cariloha, Inc.$(ALOHA)$)
Other important delivery companies:
- British marijuana producer Akanda ($(AKAN)$)
- China Intelligent Parking Management System and Parking Lot Operator Youchuang Yibo Intelligent Technology Yi Po International Holdings (YBZN);
- Chinese business service provider: U-BX Technology (UBXG);
- Wuxi Li Bang International Corporation (LBGJ)
I. Sustainable Bedding Company Cariloha, Inc. (ALOHA)
Cariloha provides customers with environmentally friendly alternatives to traditional fabrics, and has successfully developed one of the brands of a full range of products and household items using bamboo fabrics. The company markets and sells its products through fast-growing e-commerce channels, modern and efficient showrooms and wholesale channels, and is committed to creating a community for environmentally conscious consumers through its clean, sustainable, effective and well-designed products. Cariloha's long-term contractual marketing partnerships with major cruise lines enable it to reach tens of thousands of new customers who visit the company's independent showrooms in high-traffic destinations and cruise ports of call.
As of September 30, 2021, the company's bedding category (which accounts for 68% of revenue) offers 184 SKUs with prices ranging from $25 to $2,900. Clothing (18% of revenue) offers 6,959 SKUs at prices ranging from $10 to $89; its bathroom category (6% of revenue) offers 39 SKUs at prices ranging from $24 to $120. The company's revenue for the 12 months ended September 30, 2021 was $49 million.
II. Meihua International, a medical device supplier (Meihua International Medical Technologies$(MHUA)$) Update the prospectus
Meihua International is a disposable medical device supplier serving hospitals, pharmacies and medical institutions, and has obvious vertical medical device enterprise attributes. In terms of qualifications, the Company has Class I, Class II and Class III disposable medical device qualifications, including Class I product filing certificate and Class II-III product registration certificate, as well as China disposable medical device production and operation license. The company has more than 920 products in total, including disposable infusion pump, anesthesia puncture kit, electronic pump, general anesthesia kit, catheterization kit, gynecological examination kit, endotracheal intubation, dressing application, various tubes and other Class I, II and III products. According to the sales channels, there are more than 800 kinds of domestic products and more than 120 kinds of export products.
As of August 2021, Meihua International Medical has 61 suppliers; In terms of downstream channels, as of December 31, 2020, the company has a total of 2,869 customers, including 473 end customers, 2,095 domestic dealer customers and 301 export dealer customers
In 2019 and 2020, the company's medical care was respectivelyRevenues of US $79.6261 million and US $89.061 million were achieved, with a year-on-year increase of 12% in 2020. It is worth mentioning that the income from third-party sales accounts for the main income source of Meihua International Medical, accounting for 98.96% and 99.08% of the total income in 2019 and 2020 respectively. In the same period, the gross profit was US $32.211 million and US $37.1602 million respectively, and the gross profit margin was 40% and 42% respectively. The net profit in 2020 was US $19.0453 million, a year-on-year increase of 23.42%
In terms of SPAC,
The companies that determine the agreement include:
- Leading multinational lottery operator Allwyn Entertainment and Special Purpose Acquisition Corporation$Cohn Robbins Holdings Corp(CRHC)$Merge;
- BitFuFu, a leading digital asset cloud mining service provider, and$Arisz Acquisition Corp(ARIZ)$Reach a final merger agreement;
- Visual effects and animation company DNEG will work with$Sports Ventures Acquisition Corp.(AKIC)$Merge;
- Akili Interactive, a leading enterprise in digital medicine, and$Social Capital Suvretta Holdings Corp. I(DNAA)$Merger and listing;
- Aerospace logistics market leader D-Orbit S.p.A. and$Breeze Holdings Acquisition Corp(BREZ)$Merger and listing;
- Apifiny Group Inc., a cross-exchange global digital asset trading platform, announced plans to pass a$Abri SPAC I Inc(ASPA)$Merger and listing;
- ETAO International Group, a Chinese telemedicine platform, will cooperate with special purpose acquisition companies$Mountain Crest Acquisition Corp. II Rights(MCADR)$Merger and listing;
- Comera Life Sciences, an innovative drug company, will pass the$OTR Acquisition Corp(OTRA)$Business merger and listing;
- Kalera will pass the$Agrico Acquisition Corp(RICO)$The merger is listed on NASDAQ;
- MariaDB Corporation Ab and$Agrico Acquisition Corp(RICO)$Merge into a listed company;
- Calidi Biotherapeutics and$Edoc Acquisition Corp(ADOC)$Agree to merge and create a listed clinical biotechnology company
- Pet company Wag Labs, Inc. will pass the$Edoc Acquisition Corp(ADOC)$Business merger and listing
Comments